Staring at a deep red light for three minutes a day can significantly improve declining eyesight, finds a new UCL-led study, the first of its kind in humans. Scientists believe the discovery, published in the Journals of Gerontology, cou

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed count

A U.S. Patent for a "Customizable Facility" was awarded to Lonza on June 23rd, 2020. The present invention is a campus for fabricating at least one pharmaceutical product, the campus comprising: a plu

The U.S FDA has approved Zogenix's drug to treat seizures associated with a rare form of childhood epilepsy known as Dravet syndrome. The drug, branded as Fintepla, uses a low-dose liquid solution of fenfluramine, which was used in an obes

OSIsoft, perhaps best known in our community for its industry standard PI platform on which so many rely to manage their bioprocess data and more, could be sold for upwards of $4B+ in the coming months according to people familiar with

Sanofi is considering cutting hundreds of jobs and will discuss potential steps with staff representatives over the coming days, five sources said this week. Management has begun meeting with staff representatives to outline a restructurin

UniQure has sold off the rights to its experimental gene therapy for hemophilia B, announcing this week that it is licensing the treatment to CSL Behring for $450 million in cash. The Dutch gene therapy developer could receive as much as $

Kymab has announced that the Supreme Court of the United Kingdom has held that all of the claims of two patents, often referred to as the 'Murphy patents', owned by Regeneron that were asserted against Kymab are invalid. The Court's decisi

Some common strains of influenza have the potential to mutate to evade broad-acting antibodies that could be elicited by a universal flu vaccine, according to a study led by scientists at Scripps Research. The findings highlight the challe

Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist Kazuhide Sato and colleagues tested the treatment and published their findings i

A new guidance from the US FDA clarifies how manufacturers of drugs and biological products should address COVID-19 infection in their employees. Generally speaking, employees who are ill or infected with SARS-CoV-2, the novel coronavirus,